INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Penumbra, Inc.
NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Penumbra, Inc. (“Penumbra” or the “Company”) (NYSE: PEN). The investigation focuses on whether Penumbra issued false and/or misleading statements and/or failed to disclose information pertinent to investors concerning the Company’s scientific research.
On December 8, 2020, Quintessential Capital Management released a follow-up short report, alleging that some of the company’s scientific research pieces appear to have been authored by a fake individual.
On this news the Company’s shares fell by $19.95 per share, or approximately 9%, to close at $204.07 per share on December 8, 2020.
If you purchased or otherwise acquired Penumbra securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-371-6600
https://www.kmllp.com
investigations@kmllp.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
